McGill researchers working on organ chip that predicts cancer treatment

Researchers at McGill University are working on a new organ chip that will allow them to predict how cancer treatment will affect patients.

The new tech comes as doctors have found that not all cancer treatment works the same for everyone. Some patients who have advance cancer who are still eligible for surgery usually receive neoadjuvant chemotherapy to shrink the tumour and improve surgical outcomes, but some tumors are resistant to that treatment.

Due to this, McGill University has been working on a device called an organ-on-a-chip, which will allow doctors to recreate the patient’s cancer and surrounding tissues, allowing doctors to predict how the cancer will respond to treatment.

“This is the first time we have been able to reproduce, outside the body, not only a person’s cancer b